Maintain 21 CFR Part 11 Compliance for Pharmaceutical and Medical Device Organizations
Food and Drug Administration (FDA) requirements around electronic signature, specifically regarding Title 21 CFR Part 11 compliance are of top importance to Life Sciences organizations.
Watch this on-demand webinar and learn how you can maintain a compliant environment in your organization by deploying DocuSign’s electronic signature solution. In DocuSign’s upcoming release, we have added enhanced functionality to enable companies like yours to utilize DocuSign in a 21 CFR Part 11 compliant manner.
With DocuSign, you can automate your sampling process, keep audit trails on documents, implement controls and more. Watch today to learn how you can enable DocuSign’s electronic signature solution to meet compliance regulations across your organization.